Is HCV Drug Development Nearing Its End?

The FDA recently approved two new combination regimens for hepatitis C, raising the question of whether further drug development is warranted in this area. Gilead’s Vosevi (sofosbuvir/velpatasvir/voxilaprevir) and AbbVie’s Mavyret...

AGA Award Nominations Window Closes Tomorrow

2017-09-26 20:01:59 UTC AGA members: Find this interesting? Share your thoughts with colleagues in AGA Community. Sept. 28, 2017 Want to honor a colleague for a highly coveted award? Submit your nomination(s) by tomorrow, Sept. 29 for AGA Recognition Prizes and the...

My Inaugural Visit to Capitol Hill

2017-09-27 20:01:34 UTC AGA members: Find this interesting? Share your thoughts with colleagues in AGA Community. Sept. 28, 2017 Dr. Nice Toriz learned that it’s urgent to participate in advocacy to ensure that Congress hears the voice of GI. By Nice Toriz, MD,...
The Current State of Professional Burnout in Gastroenterology

The Current State of Professional Burnout in Gastroenterology

2017-09-27 17:52:47 UTC AGA members: Find this interesting? Share your thoughts with colleagues in AGA Community. Sept. 27, 2017 Results from a new survey are in. Burnout is increasing among GIs and most might not realize that they are suffering from it. Some degree...